Related Experiment Video
Updated: Jul 14, 2026
07:48
Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
Chemogenomics approaches to novel target discovery
1Novartis Institutes for Biomedical Research, Developmental & Molecular Pathways, Cambridge, MA 02139, USA. alex.gaither@novartis.com
Expert Review of Proteomics
|June 8, 2007
Summary
Chemogenomics integrates compound effects with genomics for novel drug discovery. This approach accelerates the identification of targeted therapies and disease pathways, particularly in cancer research.
Area of Science:
- Genomics
- Pharmacology
- Bioinformatics
Background:
- Chemogenomics combines compound screening with genomics.
- Novel in silico tools are developed for data analysis.
- Complex databases pose challenges in mining compound-target interactions.
Purpose of the Study:
- To explore the role of chemogenomics in drug discovery.
- To highlight the use of in silico tools for data analysis.
- To demonstrate the potential of chemogenomics in identifying targeted therapies.
Main Methods:
- Integrating compound effects on biological targets with genomics.
- Utilizing in silico tools for systematic data profiling and analysis.
- Employing RNA interference-based screening alongside chemical screens.
Main Results:
- Chemogenomics enables parallel mapping of chemical and biological space.
- The approach aids in discovering new therapeutic entities.
- It facilitates rapid validation of novel targeted therapeutics.
- Identifies pathway nodes relevant to multiple diseases, including cancer.
Conclusions:
- Chemogenomics accelerates the discovery of targeted therapies.
- It offers a novel method for identifying disease-associated genes.
- The integration of chemical and RNA interference screens is transformative for therapeutic discovery.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:33Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...